| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |